We are live on ! Find out more
MWR

McAdams Wright Ragen Portfolio holdings

AUM $1.79B
1-Year Est. Return 13.95%
This Fund
S&P 500
This Quarter Est. Return
-0.99%
1 Year Est. Return
+13.95%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.79B
AUM Growth
-$285K
Cap. Flow
+$28.6M
Cap. Flow %
1.6%
Top 10 Hldgs %
25.41%
Holding
452
New
56
Increased
179
Reduced
158
Closed
31

Top Sells

Rank Stock Value
1
CCL icon
Carnival Corporation Ltd
CCL
+$15.7M
2
AAPL icon
Apple
AAPL
+$10M
3
FFIV icon
F5
FFIV
+$7.93M
4
RIG icon
Transocean
RIG
+$7.54M
5
INTC icon
Intel
INTC
+$7.25M

Sector Composition

Rank Sector Weight
1 Technology 14.62%
2 Healthcare 14.27%
3 Industrials 12.51%
4 Real Estate 9.66%
5 Energy 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESLT icon
201
Elbit Systems
ESLT
$36.3B
$994K 0.06%
16,025
+2,425
+18% +$148K
CLX icon
202
Clorox
CLX
$11.6B
$942K 0.05%
9,809
+3,701
+61% +$335K
IJH icon
203
iShares Core S&P Mid-Cap ETF
IJH
$123B
$942K 0.05%
34,465
+5,600
+19% +$158K
MDT icon
204
Medtronic
MDT
$105B
$941K 0.05%
15,202
-2,150
-12% -$137K
PPG icon
205
PPG Industries
PPG
$25.8B
$907K 0.05%
9,222
+6,814
+283% +$694K
VBK icon
206
Vanguard Small-Cap Growth ETF
VBK
$23.6B
$904K 0.05%
7,511
-2
-0% -$248
WBA
207
DELISTED
Walgreens Boots Alliance
WBA
$878K 0.05%
14,825
+1,001
+7% +$65.7K
CLIR icon
208
ClearSign Technologies
CLIR
$21.1M
$870K 0.05%
13,025
+6,835
+110% +$524K
NVS icon
209
Novartis
NVS
$294B
$855K 0.05%
10,138
-107
-1% -$8.66K
ORAN
210
DELISTED
Orange
ORAN
$846K 0.05%
57,420
+2,805
+5% +$42.6K
ALL icon
211
Allstate
ALL
$64.8B
$817K 0.05%
13,328
+6,659
+100% +$400K
MTB icon
212
M&T Bank
MTB
$36B
$787K 0.04%
6,387
-5,854
-48% -$721K
VTI icon
213
Vanguard Total Stock Market ETF
VTI
$662B
$785K 0.04%
7,760
-250
-3% -$25.6K
MDLZ icon
214
Mondelez International
MDLZ
$76.8B
$773K 0.04%
22,583
+3,651
+19% +$133K
OMER icon
215
Omeros
OMER
$690M
$763K 0.04%
60,013
+2,500
+4% +$35K
SJNK icon
216
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.91B
$756K 0.04%
25,265
+5,359
+27% +$163K
SYK icon
217
Stryker
SYK
$121B
$753K 0.04%
9,337
-798
-8% -$65.6K
BAX icon
218
Baxter International
BAX
$11.5B
$752K 0.04%
19,312
+13,104
+211% +$532K
VTIP icon
219
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$747K 0.04%
15,139
+1,410
+10% +$70.3K
MT icon
220
ArcelorMittal
MT
$49.6B
$746K 0.04%
+23,835
New +$792K
FAX
221
abrdn Asia-Pacific Income Fund
FAX
$608M
$735K 0.04%
20,784
+110
+0.5% +$4.04K
CELG
222
DELISTED
Celgene Corp
CELG
$731K 0.04%
7,714
-1,718
-18% -$155K
QQQ icon
223
Invesco QQQ Trust
QQQ
$471B
$730K 0.04%
7,394
-99
-1% -$9.64K
EXG icon
224
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.96B
$722K 0.04%
+72,000
New +$741K
MCHB
225
Mechanics Bancorp
MCHB
$3.55B
$707K 0.04%
41,405
+8,575
+26% +$153K

Similar funds

McAdams Wright Ragen's Q3 2014 Portfolio in Review

As of Q3 2014, McAdams Wright Ragen held 452 positions worth $1.79B, down 0.02% from $1.79B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

McAdams Wright Ragen's Q3 2014 filing shows 56 new, 179 increased, 158 reduced and 31 closed positions. Its largest new stake was AbbVie: 620,414 shares worth $35.8M. The largest sale was Carnival Corporation Ltd, an estimated $15.7M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.

  • McAdams Wright Ragen's largest Q3 2014 buy was AbbVie: 620,414 shares worth $35.8M.
  • McAdams Wright Ragen added most to Telefônica Brasil in Q3 2014, an estimated $19.8M increase.
  • McAdams Wright Ragen's biggest Q3 2014 reduction was Carnival Corporation Ltd, cutting an estimated $15.7M.
  • McAdams Wright Ragen fully exited Timken Company in Q3 2014, selling an estimated $2.71M.
  • McAdams Wright Ragen's ten largest holdings make up 25% of its $1.79B portfolio in Q3 2014.
  • McAdams Wright Ragen opened 56 new positions and closed 31 in Q3 2014.
  • McAdams Wright Ragen's portfolio value fell 0.02% quarter-over-quarter to $1.79B.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.